Product spotlight: Restful Jaw helps patients with TMD
Temporomandibular joint disorder (TMD) and general jaw pain, fatigue, and soreness can stall dental procedures, and the Restful Jaw Company has created a device in
Temporomandibular joint disorder (TMD) and general jaw pain, fatigue, and soreness can stall dental procedures, and the Restful Jaw Company has created a device in
Many people have felt the jolting sensation of feeling a sharp pain in a tooth after drinking cold beverages. If the pain is caused by
A new editorial in Anesthesia Progress by Editor-in-Chief Joel M. Weaver, DDS, PhD, reminds dentists, oral surgeons, and all dental professionals that patients with obstructive
University of the Pacific’s new San Francisco campus and home of the Arthur A. Dugoni School of Dentistry has started seeing patients at its new
A Philadelphia jury has awarded $3 million to the family of a 5-year-old girl born in 2009 with bilateral cleft palate and lip after her
St. Renatus has secured a $5 million investment for its Kovacaine Mist anesthetic nasal spray, and will apply for FDA approval this year, having recently
The North Carolina State Board of Dental Examiners is planning changes to its rules on training, emergency response, and sedation following the deaths of two
Injectable local anesthetics, especially lidocaine and benzocaine, are among the most common medications administered in the dental office, and there is a real potential for
Hawaii dentists are now required to have advanced training in sedation and experience in handling emergencies following the death of a young girl who went
When patients walk into the office already in moderate to severe pain, their duress heightens the need for an effective anesthetic prior to treatment. Given
A recent report in the American Journal of Preventive Medicine (June 2012, Vol. 42:6, pp. 563-570) suggested that an additional 30 million Americans will be
A Michigan dentist has agreed to pay $125,000 to close a federal investigation into his writing of unnecessary prescriptions. Federal regulators noted that Marc Kamp,